Sign in
CompletedPhase 4

Effect of Vitamin D as Adjuvant Therapy in Preterm Infants With Neonatal Sepsis

Key facts

Who runs it
Universitas Padjadjaran
Where
Indonesia2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
78 people enrolled
Started
2 Aug 2025
Ended
8 Dec 2025
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Vitamin D
Record updated
5 February 2026

Who can take part

Age
0 days to 84 days
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Patients diagnosed with neonatal sepsis based on positive blood or cerebrospinal fluid cultures, or who meet the criteria for suspected sepsis with a Rodwell hematologic scoring system result of ≥3
  • Parents or legal guardians are willing to participate in the study and sign the informed consent form

Who cannot take part

  • Patients with major congenital malformations such as anencephaly, encephalocele, holoprosencephaly, hydrocephalus, meningomyelocele, spina bifida, omphalocele, gastroschisis, or congenital heart disease
  • If during the 7-day monitoring period, a patient who was initially able to feed develops a medical condition requiring fasting (NPO)
  • If during the 7-day monitoring period, a patient who initially had a medical condition requiring fasting is later able to feed again

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn the effect of vitamin D as an adjunctive therapy for preterm neonates with sepsis measured by the outcomes, which are sepsis score and C-reactive protein after 7 days. The main questions it aims to answer are:

Read full original descriptionShow less

Is there a difference in the results of the sepsis score (Modified Tollner Score and Sepsis Prediction Score) between groups of preterm neonates with sepsis who were given vitamin D as adjuvant therapy at doses of 400 IU/day, 800 IU/day, and those who were only given antibiotics?

Is there a difference in CRP levels between groups of preterm neonates with sepsis who were given vitamin D as adjuvant therapy at doses of 400 IU/day, 800 IU/day, and those who were only given antibiotics?

Participants will be divided into 3 groups:

Group 1 consisted of subjects who were given only antibiotics due to medical conditions requiring fasting.

Group 2 consisted of subjects who were able to receive enteral nutrition, were given antibiotics, and were supplemented with vitamin D3 at a dose of 400 IU once daily for 7 days.

Group 3 consisted of subjects who were able to receive enteral nutrition, were given antibiotics, and were supplemented with vitamin D3 at a dose of 800 IU once daily for 7 days.

The 3 groups in the trial

  • Antibiotics onlyNo study treatment, for comparison

    Group 1 consisted of subjects who were given only antibiotics due to medical conditions requiring fasting.

  • Vitamin D 400 IUExisting treatment, for comparison

    Group 2 consisted of subjects who were able to receive enteral nutrition, were given antibiotics, and were supplemented with vitamin D3 at a dose of 400 IU once daily for 7 days.

    Treatment: Vitamin D

  • Vitamin D 800 IUExisting treatment, for comparison

    Group 3 consisted of subjects who were able to receive enteral nutrition, were given antibiotics, and were supplemented with vitamin D3 at a dose of 800 IU once daily for 7 days.

    Treatment: Vitamin D

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effect of Vitamin D Administration on Sepsis Score and C-Reactive Protein Levels in Preterm Infants With Neonatal Sepsis
Publications
Record updated
5 February 2026